|
|
On-Track
To Develop The World's First SARS Vaccine, Sinovac Is
A Success Story in the Making
By
Marc Davis, Managing Editor
December, 2003
Another
global outbreak of the deadly and highly infectious
SARS virus could prove far more devastating than when
it first appeared a year ago, scientists are now predicting.
That is why the race is on to launch the world's first
breakthrough vaccine as the initial line of defence
against SARS (severe acute respiratory syndrome).
read
full article
|
|
International
Wex Technologies Inc. Anticipates Positive Trial Results
By
Marc Davis, Managing Editor
September, 2003
Read
full article - (Adobe PDF Format) |
|
|
PharmaGap
Unlocks Secrets Of Cellular Biology To Counteract Cancer
And Other Deadly Diseases
By
Marc Davis, Managing Editor
May, 2003
PharmaGap
Inc. (TSX.V-GAP) (www.pharmagap.com), a Canadian biotech,
is pioneering a revolutionary approach to treat cancers,
neurodegenerative diseases, and many other serious illnesses.
read
full article
|
|
|
InNexus
Finds Fast Track To Capitalize On Multi-Billion Dollar
'Monoclonal Antibody' Market
By
Marc Davis, Managing Editor
January 2003
The
prospect of finding a cure for cancer and other pervasive
life-threatening diseases may still be some years away.
But recent medical breakthroughs in 'monoclonal antibody'
genetic engineering are now making it possible for patients'
immune systems to fight back.
read
full article
|
| |
|
|
|
